Hiroshi Torii
Impact in
- Biochemistry top 10%
- Amino Acid Enzymes and Metabolism
-
- Mitochondrial Function and Pathology
- Coenzyme Q10 studies and effects
- Polyamine Metabolism and Applications
- Microbial Metabolic Engineering and Bioproduction
Papers in
-
- Antibiotics Pharmacokinetics and Efficacy 3
- Pharmacogenetics and Drug Metabolism 3
- Co-authors
- Shigeharu Tanayama (8 shared papers)Kiyoshi Yoshida (8 shared papers)Atsushi Kakinuma (2 shared papers)Tsuneo Asano (2 shared papers)Yukio Sugino (1 shared paper)Hideaki Yamada (2 shared papers)Hidehiko Kumagai (2 shared papers)Hitoshi Enei (2 shared papers)
- Journals
- Xenobiotica (2 papers)Journal of Polymer Science Part A Polymer Chemistry (2 papers)Biochemical and Biophysical Research Communications (2 papers)Antimicrobial Agents and Chemotherapy (1 paper)Chemotherapy (1 paper)
- Partner nations
- JapanUnited KingdomUnited States
In The Last Decade
Hiroshi Torii
14 papers receiving 327 citations
Peers
Comparison fields: 5 of 80
- Biochemistry 53
- Molecular Biology 207
- Pharmacology 19
- Clinical Biochemistry 14
- Cellular and Molecular Neuroscience 36
Countries citing papers authored by Hiroshi Torii
This map shows the geographic impact of Hiroshi Torii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Torii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Torii more than expected).
Fields of papers citing papers by Hiroshi Torii
This network shows the impact of papers produced by Hiroshi Torii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Torii. The network helps show where Hiroshi Torii may publish in the future.
Co-authors
The 17 scholars most cited alongside Hiroshi Torii, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1972 | 72 | |
| 2 | 1981 | 69 | |
| 3 | 1962 | 53 | |
| 4 | 1985 | 47 | |
| 5 | 1985 | 17 | |
| 6 | 1985 | 17 | |
| 7 | 1985 | 16 | |
| 8 | 1972 | 16 | |
| 9 | 1996 | 12 | |
| 10 | 1984 | 10 | |
| 11 | 1986 | 7 | |
| 12 | 1984 | 6 | |
| 13 | Metabolic fate of cefotiam hexetil, a new oral cephalosporin antibiotic, in rats, mice, and dogs | 1988 | 3 |
| 14 | 1980 | 2 | |
| 15 | 1996 | 1 |
About Hiroshi Torii
Hiroshi Torii is a scholar working on Molecular Biology, Pharmacology, Pharmacology, Materials Chemistry and Oncology, having authored 15 papers that have together received 348 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Amino Acid Enzymes and Metabolism (2 papers), Muscle metabolism and nutrition (2 papers), Pickering emulsions and particle stabilization (2 papers), Enzyme Structure and Function (2 papers) and Advanced Polymer Synthesis and Characterization (2 papers). The work is most often cited by research in Biochemistry (53 citations), Molecular Biology (207 citations), Pharmacology (19 citations), Clinical Biochemistry (14 citations) and Cellular and Molecular Neuroscience (36 citations). Hiroshi Torii has collaborated with scholars based in Japan, United Kingdom and United States. Frequent co-authors include Shigeharu Tanayama, Kiyoshi Yoshida, Atsushi Kakinuma, Tsuneo Asano, Yukio Sugino, Hideaki Yamada, Hidehiko Kumagai, Hitoshi Enei, Nobukazu Kashima and Shinji Okumura. Their work appears in journals such as Xenobiotica, Journal of Polymer Science Part A Polymer Chemistry, Biochemical and Biophysical Research Communications, Antimicrobial Agents and Chemotherapy and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.